Close
Add Shasun Pharmaceuticals Ltd. To PortFolio
Date of purchase
Calendar
Quantity
Purchase price
Close
Add to Watchlist
Alert me if Shasun Pharmaceuticals Ltd.
Goes above Rs
Goes below Rs
Close
rediff.com
Home
My Portfolio
My Watchlist
Global Trends
Stock Calls
More
More
Hi Guest
X
Investment Tool
Forex
Indices
Sectors
Mutual Funds
Gainers / Losers
All Pages
Real-Time Quote
Enter Company or MF
Company
Mutual Fund
All
Shasun Pharmaceuticals Ltd.
BSE
|
NSE
524552 SHASUNPHA Group (T) BSE data
Add to Watchlist
Day
Week
Month
6 Months
Year
Zoom
How hot is this stock?
© Rediff.com
Price*
Volume*
MF holdings
Sales
Net profit margin
* Computed on last 15 days' trading figures.
Type Numbers Only
Advanced
If you had invested…
Rs
ago
You would have
Rs 00,00,00,000.00
Also check - Nifty, Sensex, Gold, FDs …
* Based on prev close (src - Rediff MoneyWiz)
Report card
Attribute
Value
Date
PE ratio
124.36
23/05/12
EPS (Rs)
1.01
Mar, 11
Sales (Rs crore)
212.48
Dec, 11
Face Value (Rs)
2
Net profit margin (%)
0.85
Mar, 11
Last bonus
1:2
11/07/95
Last dividend (%)
100
12/03/12
Return on average equity
2.84
Mar, 11
Research centre
Results
Quarterly
-
Half yearly
-
Annual
Statement
Balance sheet
-
P&L
-
Cash flow
More
Dividend
-
Bonus
-
Share holding
Capital structures
-
Ratio
MFs invested in this company
Scheme
% of asset size
Sundaram S.M.I.L.E.Fund - Growth
6.00
Sundaram S.M.I.L.E.Fund - Institutional Plan - Growth
6.00
Sundaram S.M.I.L.E.Fund - Dividend
6.00
Sundaram S.M.I.L.E.Fund - Institutional Plan - Dividend
6.00
ING Retireinvest Fund Series 1 - Growth
0.78
Announcements
More
17 May
Board to consider Dividend
24 Apr
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
24 Apr
Disclosures under Reg.13(4),13(4A)and13(6) of SEBI (Prohibition of Insider Trading) Regulations,1992
23 Apr
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
23 Apr
Disclosures under Reg.13(4),13(4A)and13(6) of SEBI (Prohibition of Insider Trading) Regulations,1992
20 Apr
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
18 Apr
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
18 Apr
Shasun turnover crosses Rs. 1000 crores as it celebrates its 35 years of service to the pharmaceutical industry
18 Apr
Disclosures under Reg.13(4),13(4A)and13(6) of SEBI (Prohibition of Insider Trading) Regulations,1992
18 Apr
Disclosures under Reg.13(4),13(4A)and13(6) of SEBI (Prohibition of Insider Trading) Regulations,1992
Compare with
Company
Prev close
Cipla (Sensex)
309.20
Sun Pharma. (Sensex)
571.35
Apollo Hospitals (A)
632.10
AstraZeneca Pharma I (A)
1,922.85
Aurobindo Pharma (A)
107.70
Biocon (A)
215.00
Cadila Healthcar (A)
735.20
Divi's Lab (A)
944.85
Dr. Reddy's Labs (A)
1,675.60
Fortis Healthcare (A)
95.35
Mutual Fund Selector
Find the fund that is right for you
Buy? Sell? Hold?
Get the Latest Stock Tips
All MoneyWiz Pages
Stocks
A-Z
Stock Tips
Gainers -
Daily
|
Weekly
|
Monthly
Losers -
Daily
|
Weekly
|
Monthly
Group-wise listing
IPO
|
Top IPOs
Recent IPOs
|
IPO News
Similar Price band
Most traded - By volumes
Top 100 - By market capitalisation
Latest Company Results
Management Speaks
Mutual Funds
Top 25 schemes
Equity - ELSS
High-risk, High-returns
Equity - Index Funds
Medium-risk, Medium-returns
Equity - Sector Funds
Low-risk, Low-returns
Equity - Balance Fund
Gilt Funds
Equity - Diversified Fund
Funds of Funds
MF News
Special Funds
Liquid Funds
Dynamic Asset Allocation
NFOs
MF Selector
Investment tracking
My Portfolio
My Watch List
If You Had Invested...
Market Information
Global Indicators
Forex Converter
Live: Market Commentary
Market Indices
Sectoral Indices
World Indices
Chart -
Sensex
|
Nifty
Market Astrology